Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 30.02 $ 0.53 (1.8 %)    

Wednesday, 17-Jul-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.23 $ -14.57 (-2.94 %)
DIA $ 412.29 $ 2.27 (0.55 %)
SPY $ 557.05 $ -7.92 (-1.4 %)
TLT $ 94.21 $ 0.02 (0.02 %)
GLD $ 227.29 $ -1.06 (-0.46 %)
$ 30.03
$ 29.40
$ 30.00 x 112
$ 30.04 x 105
$ 29.36 - $ 30.30
$ 24.83 - $ 35.80
45,394,967
na
171.08B
$ 0.57
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-08-2023 10-01-2023 10-Q
4 08-09-2023 07-02-2023 10-Q
5 05-10-2023 04-02-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 10-02-2022 10-Q
8 08-10-2022 07-03-2022 10-Q
9 05-11-2022 04-03-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-12-2021 10-03-2021 10-Q
12 08-12-2021 07-04-2021 10-Q
13 05-13-2021 04-04-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-27-2020 10-Q
16 08-06-2020 06-28-2020 10-Q
17 05-07-2020 03-29-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-29-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 07-01-2018 10-Q
25 05-10-2018 04-01-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 10-01-2017 10-Q
28 08-10-2017 07-02-2017 10-Q
29 05-11-2017 04-02-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 10-02-2016 10-Q
32 08-11-2016 07-03-2016 10-Q
33 05-12-2016 04-03-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-27-2015 10-Q
36 08-06-2015 06-28-2015 10-Q
37 05-07-2015 03-29-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-28-2014 10-Q
40 08-07-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
OPKO Health Enters Into $250M Non-Dilutive...
07/17/2024 20:15:37

Core News & Articles
Pfizer And Valneva Announce Primary Vaccin...
07/17/2024 20:02:27

Participants completed primary vaccination series (3 doses) with VLA15 Primary vaccination series to be followed by a booster a...

european-commission-faces-court-criticism-over-covid-vaccine-contract-transparency-ahead-of-vote-on-ursula-von-der-leyens-reappointment
European Commission Faces Court Criticism ...
07/17/2024 18:24:05

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implication...

Core News & Articles
CNBC Halftime Report Final Trades: Pfizer,...
07/17/2024 17:01:24

pfizer-and-roche-advance-on-their-weight-loss-drug-journeys
Pfizer And Roche Advance On Their Weight L...
07/17/2024 14:48:52

After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, P...

Core News & Articles
CytoReason Secures $80M From OurCrowd, NVI...
07/17/2024 12:13:56

New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to ...

wall-streets-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Say B...
07/15/2024 18:08:21

decoding-pfizers-options-activity-whats-the-big-picture
Decoding Pfizer's Options Activity: What's...
07/15/2024 17:01:29

viiv-healthcare-to-announce-data-from-randomised-clinical-trial-for-2-drug-regimen-dovato-against-3-drug-regimen-biktarvy-at-aids-2024
Viiv Healthcare To Announce Data From Rand...
07/15/2024 12:33:01

Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain exper...

inflation-drop-fuels-rate-cut-speculation-investors-shift-to-sector-laggards-russell-2000-surges-over-36-this-week-in-the-markets
Inflation Drop Fuels Rate Cut Speculation,...
07/12/2024 20:33:07

Inflation drops, speculations rise on interest rate cuts. Producer inflation data fails to alter expectations, tech sector unde...

with-oral-anti-obesity-candidate-development-pfizer-seeks-relevant-and-competitive-presence---goldman-sachs
With Oral Anti-Obesity Candidate Developme...
07/12/2024 16:26:42

Pfizer has selected its preferred once-daily modified release formulation for danuglipron, an oral GLP-1 receptor agonist, with...

pfizer-l3harris-technologies-and-more-cnbcs-final-trades
Pfizer, L3Harris Technologies And More: CN...
07/12/2024 13:14:57

Pfizer selected Danuglipron, its once-daily weight loss drug, for continued advancement based on an ongoing pharmacokinetic study.

why-pfizer-stock-is-moving-higher-on-thursday
Why Pfizer Stock Is Moving Higher on Thursday
07/11/2024 17:34:58

Pfizer announced it will advance development of its once-daily Danuglipron.

Core News & Articles
CNBC Halftime Report Final Trades: Pfizer,...
07/11/2024 17:02:07

pfizer-advances-once-daily-weight-loss-pill-as-it-catches-up-to-tap-the-lucrative-market
Pfizer Advances Once-Daily Weight-Loss Pil...
07/11/2024 13:45:33

Pfizer advances its once-daily modified release formulation for danuglipron, an oral GLP-1 receptor agonist, after positive Pha...

Core News & Articles
CureVac Announced The Latest Trial Dates F...
07/11/2024 11:20:10

New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics. First...

pfizer-announced-that-based-on-results-from-the-ongoing-pharmacokinetic-study-the-company-has-selected-its-preferred-once-daily-modified-release-formulation-for-danuglipron-pfizer-plans-to-conduct-dose-optimization-studies-in-the-second-half-of-2024
Pfizer Announced That Based On Results Fro...
07/11/2024 10:50:31

barclays-maintains-equal-weight-on-pfizer-raises-price-target-to-30
Barclays Maintains Equal-Weight on Pfizer,...
07/10/2024 23:23:43

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $28 to $30.

pfizer-and-mainz-provide-examples-of-using-emerging-technology-for-good
Pfizer And Mainz Provide Examples Of Using...
07/10/2024 17:04:40

This week, Pfizer Inc (NYSE: PFE) revealed a new collaboration to unlock new therapeutic approaches. Its smaller European indus...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/10/2024 14:08:31

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)